Ethnically diverse mini-liver manufacturer secures £1m in grant funding and investment round

Cytochroma, a life sciences company which provides ethical, sustainable and accurate alternatives to animal testing in drug discovery and development, has secured nearly £1m to further commercialise its business.

This follows a successful investment round led by Angel Academe alongside fellow female-focused group Investing Women Angels (IWA) and Cambridge Capital

Group. IWA has also mentored the company’s founder Kate Cameron, who was a 2021 AccelerateHER Awards winner. Scottish Enterprise has provided match co-investment funding for the private equity investment round.

Additional investment has been generated through multiple grants from Scottish Enterprise and Innovate UK. Cytochroma has also had success in numerous business competitions which have provided significant funding to date.

Read more HERE.